Note: Elysium Therapeutics's revenues are gauged from an analysis of company filings.
Elysium Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
November 16, 2020
Complete list of funding rounds and total amounts in the Company Report
Elysium Therapeutics's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Elysium Therapeutics Revenue (Sales)
Cost of Goods Sold
Salaries and wages
Other Operating Expenses
Total Operating Expenses
EBIT (Earnings Before Interest and Taxes)
Determine whether Elysium Therapeutics grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Elysium Therapeutics is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Elysium Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Elysium Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Elysium Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Elysium Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.